Home›Search›Piel

Piel

Ediciones Doyma, S.L. · Spain · Est. 2001

ISSN1578-8830

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q446

Total46

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.105

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.034

Total Worksi

4,401

Total Citationsi

3,223

2yr Mean Citednessi

0.03

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Piel is a journal oriented towards continuing education in dermatology. Its interest extends to dermatologists and physicians who practice outside of large centers.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionSpain

Primary Language—

1st Year Published2001

Annual Volume~ 176 articles / year

StatusActive (last: 2026)

Total Publications4,401

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/12 · 42%

✅

Do you know the journal / publisher?

Ediciones Doyma, S.L.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1578-8830

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

188

2019

189

2020

240

2021

150

2022

148

2023

183

2024

197

2025

173

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

DermatologyQ4

Subject Classification

Scopus Categories

Dermatology

Research Topics (OpenAlex)

Autoimmune Bullous Skin DiseasesCancer and Skin LesionsGenetic and rare skin diseases.Cutaneous lymphoproliferative disorders researchNail Diseases and TreatmentsAutoimmune and Inflammatory DisordersNonmelanoma Skin Cancer StudiesDermatological and Skeletal DisordersTumors and Oncological CasesCutaneous Melanoma Detection and Management

Frequently asked questions about Piel

Is Piel a predatory journal?

PubScope has no integrity flags on record for Piel: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 46/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Piel?

Piel is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.105.

Is Piel indexed in Scopus and Web of Science?

Piel is indexed in Scopus.